#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis I Acute graft versus host disease in liver Prader-Willi syndrome Endometrial adenocarcinoma Transitional cell cancer of the renal pelvis and ureter Hepatic angiosarcoma Fusarium infection Systemic sclerosis pulmonary Henoch-Schonlein purpura Neuropathy peripheral Cytomegalovirus infection Pelizaeus-Merzbacher disease Urethral valves Congenital nephrogenic diabetes insipidus Cushing's syndrome More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic Kearns-Sayre syndrome – Life with Disease Metachromatic leukodystrophy – Life with Disease Mast cell activation syndrome – Trials in Disease Angelman’s syndrome – Life with Disease Primary hyperoxaluria – Treatment Alport’s syndrome – Life with Disease Brain stem glioma – Life with Disease Indolent systemic mastocytosis – Treatment Optic glioma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oxybuprocaine Hydrochloride AGALSIDASE BETA ULVIPRUBART Pyridoxine Hydrochloride Sulfasalazine Pozelimab Ziltivekimab Zidovudine Ds-3939A Ima402 Pyrimethamine Goserelin Acetate Dorocubicel Emibetuzumab Sorafenib Mometasone Brentuximab Vedotin Immunoglobulin M Mecillinam Salbutamol Sulfate More therapies…

    Learn about Your Condition

    Dyspepsia Oral neoplasm Aortic aneurysm Chronic myeloid leukaemia Renal cancer Ligament sprain Dysmenorrhoea Lung adenocarcinoma Latent tuberculosis Diffuse large B-cell lymphoma Gastric cancer recurrent Pneumonia Lyme disease Status epilepticus Hypoxia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Type 2 diabetes mellitus

  • Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Czechia Germany Greece

  • Study on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Insulin Glargine
    • Insulin Icodec
    • Metformin
    Greece Italy Poland

  • Study on Retatrutide and Placebo for Kidney Function in Overweight or Obese Patients with Chronic Kidney Disease, with or without Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Type 2 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Iohexol
    • Ly3437943 Sodium
    Italy Spain

  • Study on the Effects of Finerenone on Kidney Health in Patients with Type 2 Diabetes

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Finerenone
    • Iohexol
    • L-Arginine Hydrochloride
    Germany

  • Study on Heart Health in Type 2 Diabetes Patients Using Semaglutide and Dapagliflozin Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Atenolol
    • Glyceryl Trinitrate
    • Iomeprol
    Denmark

  • Study on Ertugliflozin for Children and Teens with Type 2 Diabetes

    Not recruiting

    3 1
    Investigated Drugs:
    • Ertugliflozin
    Hungary Italy Poland
Previous Page
1 … 11 12 13 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!